Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B ; volume:22 ; number:1 ; day:17 ; month:3 ; year:2022 ; pages:1-10 ; date:12.2022
BMC cardiovascular disorders ; 22, Heft 1 (17.3.2022), 1-10, 12.2022
- Urheber
-
Williams, Katie B.
Horst, Michael
Young, Millie
Pascua, Christine
Puffenberger, Erik G.
Brigatti, Karlla W.
Gonzaga-Jauregui, Claudia
Shuldiner, Alan R.
Gidding, Samuel
Strauss, Kevin A.
Chowdhury, Devyani
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-022-02539-3
- URN
-
urn:nbn:de:101:1-2022060919540559133213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Williams, Katie B.
- Horst, Michael
- Young, Millie
- Pascua, Christine
- Puffenberger, Erik G.
- Brigatti, Karlla W.
- Gonzaga-Jauregui, Claudia
- Shuldiner, Alan R.
- Gidding, Samuel
- Strauss, Kevin A.
- Chowdhury, Devyani
- SpringerLink (Online service)
Ähnliche Objekte (12)
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
An update on lipid apheresis for familial hypercholesterolemia
Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
An update on lipid apheresis for familial hypercholesterolemia
Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
An update on lipid apheresis for familial hypercholesterolemia